1. Department of Radiation Oncology, University Hospital of Besançon, Besançon, France;
2. Department of Biostatistics, Georges François Leclerc Center, University of Burgundy, Dijon, France;
3. Icahn School of Medicine at Mount Sinai, New York, NY, USA;
4. Memorial Sloan Kettering Cancer Center, New York, NY, USA;
5. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;
6. Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK;
7. Medical Oncology Department, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy;
8. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;
9. Guy’s and St. Thomas’ Hospital, London, UK;
10. Heinrich-Heine-University, Düsseldorf, Germany;
11. Fred Hutchinson Cancer Research Center, Seattle, WA, USA;
12. City of Hope Comprehensive Cancer Center, Duarte, CA, USA;
13. Department of Medical Oncology, Southampton General Hospital, Southampton, UK;
14. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;
15. Department of Medical Oncology, Georges François Leclerc Cancer Center, University of Burgundy, Dijon, France;
16. Department of Radiation Oncology, Georges François Leclerc Cancer Center, University of Burgundy, Dijon, France